{"version":"1.0","type":"link","title":"Erratum: BR.31 Trial: Adjuvant Durvalumab as the Third Contender in Resected Non-Small Cell Lung Cancer.","author_name":"Remon J 외","author_url":"https://prs-insight.online/author/Remon%20J","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/95922","thumbnail_width":1200,"thumbnail_height":630}